Literature DB >> 8819213

Gastrointestinal symptoms in myotonic dystrophy.

A Rönnblom1, H Forsberg, A Danielsson.   

Abstract

BACKGROUND: Gastrointestinal complaints may be the initial symptom in myotonic dystrophy (MD). However, the frequency of gastrointestinal symptoms has never been prospectively evaluated.
METHODS: Forty patients with MD were interviewed with regard to their GI symptoms with a standardized questionnaire. A group of healthy subjects matched for age and sex served as controls.
RESULTS: The most prevalent symptoms were abdominal pain (55%), dysphagia (45%), emesis (35%), chronic or episodic diarrhoea (33%), coughing while eating (33%), and anal incontinence (30%). Twenty-five per cent of the patients considered their GI problems to be the most disabling consequence of the disease, and 28% had GI problems that started before the diagnosis of MD.
CONCLUSIONS: GI symptoms are common in patients with MD, may be the initial symptoms, and are often considered to be the most disabling consequence of the disease.

Entities:  

Mesh:

Year:  1996        PMID: 8819213     DOI: 10.3109/00365529609009145

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  14 in total

1.  Towards an integrative approach to the management of myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Luc Noreau; Richard T Moxley; Luc Laberge; Stéphane Jean; Louis Richer; Michel Perron; Suzanne Veillette; Jean Mathieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

Review 2.  Oropharyngeal dysphagia in myotonic dystrophy type 1: a systematic review.

Authors:  Walmari Pilz; Laura W J Baijens; Bernd Kremer
Journal:  Dysphagia       Date:  2014-01-24       Impact factor: 3.438

3.  Electrophysiological evaluation of oropharyngeal swallowing in myotonic dystrophy.

Authors:  C Ertekin; N Yüceyar; H Karasoy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

Review 4.  Gastrointestinal manifestations in myotonic muscular dystrophy.

Authors:  Massimo Bellini; Sonia Biagi; Cristina Stasi; Francesco Costa; Maria Gloria Mumolo; Angelo Ricchiuti; Santino Marchi
Journal:  World J Gastroenterol       Date:  2006-03-28       Impact factor: 5.742

5.  Is there a difference in gastric emptying between myotonic dystrophy type 1 patients with and without gastrointestinal symptoms?

Authors:  Yuji Tanaka; Tomohiro Kato; Hiroshi Nishida; Megumi Yamada; Akihiro Koumura; Takeo Sakurai; Yuichi Hayashi; Akio Kimura; Isao Hozumi; Hiroshi Araki; Masahiko Murase; Masahito Nagaki; Hisataka Moriwaki; Takashi Inuzuka
Journal:  J Neurol       Date:  2013-01-24       Impact factor: 4.849

6.  Cricopharyngeal bar on videofluoroscopy: high specificity for inclusion body myositis.

Authors:  Kenichiro Taira; Toshiyuki Yamamoto; Madoka Mori-Yoshimura; Kazuaki Sajima; Hotake Takizawa; Jun Shinmi; Yasushi Oya; Ichizo Nishino; Yuji Takahashi
Journal:  J Neurol       Date:  2020-09-26       Impact factor: 4.849

Review 7.  Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.

Authors:  Genevieve Ho; Michael Cardamone; Michelle Farrar
Journal:  World J Clin Pediatr       Date:  2015-11-08

8.  Steinert's syndrome presenting as anal incontinence: a case report.

Authors:  Fusun Erdenen; Ahmet Burak Toros; Ayse Kubat Uzum; Sirin Sacak
Journal:  J Med Case Rep       Date:  2011-08-12

9.  Hypogonadism and erectile dysfunction in myotonic dystrophy type 1.

Authors:  Stojan Peric; Tanja Nisic; Milena Milicev; Ivana Basta; Ivan Marjanovic; Marina Peric; Dragana Lavrnic; Vidosava Rakocevic Stojanovic
Journal:  Acta Myol       Date:  2013-10

10.  High frequency of gastrointestinal manifestations in myotonic dystrophy type 1 and type 2.

Authors:  James E Hilbert; Richard J Barohn; Paula R Clemens; Elizabeth A Luebbe; William B Martens; Michael P McDermott; Amy L Parkhill; Rabi Tawil; Charles A Thornton; Richard T Moxley
Journal:  Neurology       Date:  2017-08-30       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.